Introduction

Category: Novel Psychoactive Substances (page 7)

Category: Novel Psychoactive Substances (page 7)

The NC Statewide Medical Examiner System Laboratory Approach

← Back to Series  Overview This webinar will focus on the North Carolina Medical Examiner System and the toxicology laboratory that serves the system. Included will be information on the changing landscape of death certification and changes to the laboratory…
Continue reading “The NC Statewide Medical Examiner System Laboratory Approach”…

The Industry’s Role in Responding to the Opioid Crisis

← Back to Series  Overview This webinar will describe the role that the reference material manufacturer plays by providing the tools needed to respond to the current opioid epidemic. Whether by rapidly providing authentic reference standards of novel emerging drugs…
Continue reading “The Industry’s Role in Responding to the Opioid Crisis”…

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review

Date April 2017 Overview Novel psychoactive substances (NPS) represent significant analytical and interpretive challenges to forensic and clinical toxicologists. Timely access to case reports and reports of adverse incidents of impairment or toxicity is imperative to clinical diagnosis and treatment,…
Continue reading “Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review”…